Harmony Biosciences ‘disagrees’ with Scorpion Capital’s ‘assertions’

In a statement emailed to The Fly, a spokesperson for Harmony Biosciences said the company was aware of Scorpion Capital’s report and that it disagrees with their assertions. "We are aware of this report from an activist investor and disagree with their assertions. We remain committed to helping those who live with devasting rare diseases, and our science has been subject to peer review and received global regulatory approval. We’ll continue to innovate and develop safe and effective medications for those in need. With regards to a Citizen Petition, we have not seen anything filed publicly at this time."